Background illustration for clinical trials search

Paid Clinical Trials North Carolina

Discover 2,450 paid clinical trials in North Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

for
Non-small Cell Lung Cancer
Location: Albany NY, Fairfax VA, Raleigh NC, Lincoln NE
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07554339

Phase3, Recruiting
Active & Responsive

Safety of MOON101 for the Treatment of Peanut Allergy

for
Peanut Allergy
Location: Chapel Hill NC, Atlanta GA, Ann Arbor MI,
Sponsor: Moonlight Therapeutics, Inc.

Sex: All

Age: 4 - 55

Code: NCT07580898

Phase1, Recruiting
Active & Responsive

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

for
Lung Non-Small Cell Carcinoma
Location: Bath ME, Brunswick ME, Portland ME, Scarborough ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07293247

Phase2, Recruiting
Active & Responsive

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for
Non-small Cell Lung Cancer
Location: New Haven CT, White Plains NY, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07513376

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease

for
Late-onset Pompe Disease
Location: Fairfax VA, Durham NC, St Louis MO, Irvine CA
Sponsor: Denali Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT07354724

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase2, Phase3, Recruiting
Active & Responsive

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

for
Hypoparathyroidism, Endocrine System Diseases,
Location: New York NY, Greenville NC, Chicago IL, Minneota MN,
Sponsor: Ascendis Pharma Bone Diseases A/S

Sex: All

Age: 18+

Code: NCT07081997

Phase3, Recruiting
Active & Responsive

Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections

for
Periprosthetic Joint Infection
Location: Durham NC, Charlotte NC, Lansing MI
Sponsor: OsteoRemedies, LLC

Sex: All

Age: 21+

Code: NCT06428448

Phase2, Recruiting
Active & Responsive

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

for
High-Risk Neuroblastoma
Location: The Bronx NY, Philadelphia PA, Durham NC, Toronto,
Sponsor: Renaissance Pharma Ltd.

Sex: All

Age: 1 - 18

Code: NCT07549321

Phase2, Phase3, Recruiting
Active & Responsive

PREnatal Choline and Infant Outcomes Study

for
Nutrition During Pregnancy
Location: Greenville NC
Sponsor: East Carolina University

Sex: Female

Age: 18 - 40

Code: NCT07525193

Recruiting
Active & Responsive

RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)

for
Trachoma, Eye Diseases, Trichiasis
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07322302

Recruiting
Active & Responsive

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for
Primary Sjogren's Disease
Location: Boston MA, Willow Grove PA, Chesapeake VA, Rockville MD,
Sponsor: Vor Biopharma

Sex: All

Age: 18 - 70+

Code: NCT07404865

Phase3, Recruiting
Active & Responsive

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

for
Bronchopulmonary Dysplasia (BPD), Premature Births,
Location: Amherst MA, Greenville NC, Chapel Hill NC,
Sponsor: Duke University

Sex: All

Age: 0

Code: NCT07101640

Phase1, Phase2, Recruiting
Active & Responsive

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

for
Breast Cancer, Residual Disease,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07069595

Phase2, Recruiting
Active & Responsive

Caring Connections Youth Suicide Detection and Intervention Study

for
Suicide, Suicide Prevention, Suicide Ideation, Suicide Attempt
Location: Charlotte NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 13+

Code: NCT06353711

Recruiting
Active & Responsive

NEPTUNE Match Study

for
Nephrotic Syndrome in Children,
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: University of Michigan

Sex: All

Age: 1 - 70+

Code: NCT04571658

Recruiting
Active & Responsive

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

for
Muscular Dystrophy, Facioscapulohumeral
Location: Rochester NY, Durham NC, Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 5 - 17

Code: NCT06847282

Recruiting
Active & Responsive

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07237516

Recruiting
Active & Responsive

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Chapel Hill NC, Pittsburgh PA, Columbus OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 70+

Code: NCT06997588

Phase2, Recruiting
Active & Responsive

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

for
Spinal Muscular Atrophy (SMA)
Location: Boston MA, Hartford CT, Hillsborough NC, Kissimmee FL,
Sponsor: argenx

Sex: All

Age: 5 - 17

Code: NCT07287982

Phase2, Recruiting

Popular cities in North Carolina

High PointGreensboroCharlotteDurhamWilmingtonRaleigh